Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-016461

EVP, North America Commercial sold 463 shares at $11.37 ($5,262)

  • EVP, North America Commercial acquired 1,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Grady Brendan P. · EVP, North America Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-03 Exercise or conversion : show line 1 in the form +1,166 14,622.49 D
2020-03-03 Sale : show line 2 in the form −463 $11.37 $5,262 14,159.49 D
Open-market sales · 463 sh · avg $11.37 · $5,262

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-03 Exercise or conversion : show line 3 in the form Restricted Share Units −1,166 1,166 D
Loading xslF345X03/doc4.xml…